Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) EV/EBIT Ratio: 19.23x

Is Medtronic plc’s EV/EBIT ratio high or low?

Medtronic plc's EV/EBIT ratio of 19.23x is 28% below its 5-year average of 26.81x, near the low end of its 5-year range (19.23x–61.67x).

The EV/EBIT ratio for Medtronic plc (MDT) is 19.23x as of Wednesday, June 10, 2026. It is below its 12-month average by 18.79% (23.68x).

MDT EV/EBIT Ratio Chart

MDT EV/EBIT Ratio
19.23x-19.47% 1Y
Zoom

MDT Average EV/EBIT Ratio Chart

MDT Current vs Average EV/EBIT Ratio Chart

MDT EV/EBIT Ratio Metrics

EV/EBIT RATIO

19.23x

EV/EBIT RATIO AVG TTM

23.68x

EV/EBIT RATIO AVG 3Y

24.37x

EV/EBIT RATIO AVG 5Y

26.81x

EV/EBIT RATIO AVG 10Y

27.93x

EV/EBIT RATIO AVG 15Y

24.05x

EV/EBIT RATIO AVG 20Y

21.57x

CURRENT VS TTM AVG

-18.79%

CURRENT VS 3Y AVG

-21.09%

CURRENT VS 5Y AVG

-28.29%

CURRENT VS 10Y AVG

-31.14%

CURRENT VS 15Y AVG

-20.03%

CURRENT VS 20Y AVG

-10.86%

MDT Competitors' EV/EBIT Ratio

NAMEMARKET CAPEV/EBIT RATIOTTM3Y5Y
Medtronic plc (MDT)19.23x23.68x24.37x26.81x
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B22.72x26.43x24.92x21.76x
Bristol-Myers Squibb Company (BMY)$114.14B11.98x11.36x15.41x18.91x
Elevance Health Inc. (ELV)$87.43B14.54x11.84x13.42x14.42x
CVS Health Corporation (CVS)$125.16B32.57x28.87x19.89x18.76x
Cigna Corporation (CI)$78.25B10.72x11.17x12.56x13.06x
Danaher Corporation (DHR)$130.25B27.72x30.65x32.50x29.68x
Regeneron Pharmaceuticals, Inc. (REGN)$62.59B17.96x19.47x21.84x17.76x
Pfizer Inc. (PFE)$146.36B14.13x12.23x29.86x23.38x
Intuitive Surgical, Inc. (ISRG)$146.44B45.56x63.25x73.01x67.77x

Medtronic plc EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc EV/EBIT Ratio FAQ

What is the EV/EBIT ratio for Medtronic plc (MDT)?
The EV/EBIT ratio for MDT stock is 19.23x.
Is Medtronic plc's EV/EBIT ratio high or low?
Medtronic plc's EV/EBIT ratio of 19.23x is 28% below its 5-year average of 26.81x, near the low end of its 5-year range (19.23x–61.67x).
What is the TTM average EV/EBIT ratio for Medtronic plc (MDT)?
The TTM average EV/EBIT ratio for MDT stock is 23.68x.
What is the 3Y average EV/EBIT ratio for Medtronic plc (MDT)?
The 3Y average EV/EBIT ratio for MDT stock is 24.37x.
What is the 5Y average EV/EBIT ratio for Medtronic plc (MDT)?
The 5Y average EV/EBIT ratio for MDT stock is 26.81x.
What is the 10Y average EV/EBIT ratio for Medtronic plc (MDT)?
The 10Y average EV/EBIT ratio for MDT stock is 27.93x.
What is the 15Y average EV/EBIT ratio for Medtronic plc (MDT)?
The 15Y average EV/EBIT ratio for MDT stock is 24.05x.
What is the 20Y average EV/EBIT ratio for Medtronic plc (MDT)?
The 20Y average EV/EBIT ratio for MDT stock is 21.57x.

Medtronic plc EV/EBIT Ratio History

DATEEV/EBIT RATIO
2026-06-0219.23x
2026-06-0119.28x
2026-05-2919.25x
2026-05-2819.60x
2026-05-2719.69x
2026-05-2620.02x
2026-05-2220.22x
2026-05-2120.13x
2026-05-2020.13x
2026-05-1920.22x
2026-05-1819.96x
2026-05-1519.72x
2026-05-1419.89x
2026-05-1319.73x
2026-05-1219.86x
2026-05-1119.40x
2026-05-0819.72x
2026-05-0720.09x
2026-05-0620.02x
2026-05-0520.06x
2026-05-0420.16x
2026-05-0120.50x
2026-04-3020.70x
2026-04-2920.38x
2026-04-2820.89x
2026-04-2721.10x
2026-04-2421.18x
2026-04-2321.28x
2026-04-2221.16x
2026-04-2120.91x
2026-04-2021.52x
2026-04-1721.76x
2026-04-1621.65x
2026-04-1521.95x
2026-04-1422.15x
2026-04-1322.13x
2026-04-1021.97x
2026-04-0922.11x
2026-04-0822.26x
2026-04-0721.81x
2026-04-0621.78x
2026-04-0221.85x
2026-04-0121.74x
2026-03-3121.86x
2026-03-3021.67x
2026-03-2721.96x
2026-03-2622.06x
2026-03-2522.11x
2026-03-2421.84x
2026-03-2321.96x
2026-03-2021.76x
2026-03-1921.90x
2026-03-1821.97x
2026-03-1722.22x
2026-03-1622.18x
2026-03-1321.96x
2026-03-1222.00x
2026-03-1122.33x
2026-03-1022.51x
2026-03-0922.81x
2026-03-0622.72x
2026-03-0523.15x
2026-03-0423.68x
2026-03-0323.90x
2026-03-0224.18x
2026-02-2724.09x
2026-02-2623.97x
2026-02-2523.89x
2026-02-2423.91x
2026-02-2324.92x
2026-02-2024.55x
2026-02-1924.70x
2026-02-1824.89x
2026-02-1724.46x
2026-02-1325.10x
2026-02-1225.39x
2026-02-1125.43x
2026-02-1025.50x
2026-02-0925.55x
2026-02-0625.81x
2026-02-0525.82x
2026-02-0425.59x
2026-02-0325.86x
2026-02-0225.77x
2026-01-3025.82x
2026-01-2925.41x
2026-01-2825.37x
2026-01-2725.35x
2026-01-2625.34x
2026-01-2325.39x
2026-01-2225.48x
2026-01-2125.26x
2026-01-2024.91x
2026-01-1624.53x
2026-01-1525.00x
2026-01-1424.94x
2026-01-1324.46x
2026-01-1224.57x
2026-01-0924.69x
2026-01-0824.93x
2026-01-0725.16x
2026-01-0625.27x
2026-01-0524.66x
2026-01-0224.39x
2025-12-3124.39x
2025-12-3024.51x
2025-12-2924.41x
2025-12-2624.48x
2025-12-2424.64x
2025-12-2324.68x
2025-12-2224.73x
2025-12-1924.92x
2025-12-1824.89x
2025-12-1724.85x
2025-12-1624.73x
2025-12-1524.91x
2025-12-1225.18x
2025-12-1125.15x
2025-12-1025.36x
2025-12-0925.13x
2025-12-0825.47x
2025-12-0525.49x
2025-12-0425.62x
2025-12-0325.61x
2025-12-0225.62x
2025-12-0125.90x
2025-11-2826.31x
2025-11-2626.24x
2025-11-2526.31x
2025-11-2426.16x
2025-11-2125.74x
2025-11-2025.35x
2025-11-1925.56x
2025-11-1825.66x
2025-11-1724.71x
2025-11-1424.62x
2025-11-1324.68x
2025-11-1224.61x
2025-11-1124.52x
2025-11-1023.95x
2025-11-0723.85x
2025-11-0623.40x
2025-11-0523.47x
2025-11-0423.48x
2025-11-0323.43x
2025-10-3123.53x
2025-10-3023.59x
2025-10-2923.75x
2025-10-2824.07x
2025-10-2724.26x
2025-10-2424.16x
2025-10-2324.27x
2025-10-2224.63x
2025-10-2124.61x
2025-10-2024.63x
2025-10-1724.60x
2025-10-1624.45x
2025-10-1524.51x
2025-10-1424.76x
2025-10-1324.56x
2025-10-1024.53x
2025-10-0924.75x
2025-10-0825.04x
2025-10-0725.14x
2025-10-0625.16x
2025-10-0325.01x
2025-10-0224.54x
2025-10-0124.40x
2025-09-3024.49x
2025-09-2924.22x
2025-09-2624.27x
2025-09-2524.29x
2025-09-2424.59x
2025-09-2324.43x
2025-09-2224.36x
2025-09-1924.45x
2025-09-1824.56x
2025-09-1724.35x
2025-09-1624.27x
2025-09-1524.11x
2025-09-1224.23x
2025-09-1124.28x
2025-09-1023.87x
2025-09-0924.24x
2025-09-0824.02x
2025-09-0524.00x
2025-09-0423.99x
2025-09-0323.86x
2025-09-0224.09x
2025-08-2923.98x
2025-08-2823.80x
2025-08-2723.82x
2025-08-2623.85x
2025-08-2524.32x
2025-08-2224.46x
2025-08-2124.12x
2025-08-2024.57x
2025-08-1923.86x
2025-08-1824.49x
2025-08-1524.53x
2025-08-1424.31x
2025-08-1324.51x
2025-08-1224.33x
2025-08-1124.47x
2025-08-0824.50x
2025-08-0724.15x
2025-08-0623.74x
2025-08-0523.81x
2025-08-0423.80x
2025-08-0123.73x
2025-07-3123.93x
2025-07-3024.23x
2025-07-2924.41x
2025-07-2824.30x
2025-07-2524.51x
2025-07-2424.38x
2025-07-2324.31x
2025-07-2224.23x
2025-07-2123.81x
2025-07-1823.79x
2025-07-1723.78x
2025-07-1623.83x
2025-07-1523.71x
2025-07-1423.82x
2025-07-1123.86x
2025-07-1023.75x
2025-07-0923.66x
2025-07-0823.57x
2025-07-0723.37x
2025-07-0323.53x
2025-07-0223.51x
2025-07-0123.61x
2025-06-3023.27x
2025-06-2723.02x
2025-06-2623.05x
2025-06-2523.01x
2025-06-2423.03x
2025-06-2323.00x
2025-06-2023.09x
2025-06-1824.34x
2025-06-1724.44x
2025-06-1624.85x
2025-06-1324.70x
2025-06-1224.98x
2025-06-1124.88x
2025-06-1024.86x
2025-06-0924.74x
2025-06-0624.74x
2025-06-0524.64x
2025-06-0424.31x
2025-06-0324.30x
2025-06-0223.88x
2025-05-3023.71x
2025-05-2923.58x
2025-05-2823.31x
2025-05-2723.29x
2025-05-2323.18x
2025-05-2223.23x
2025-05-2124.04x
2025-05-2024.49x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha